Alvotech USA Inc. et al v. Abbvie Inc et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Oct 22, 2021 | N/A | Case Transferred Out to Another District (0) Docket Text: Case transferred to District of Northern District of Illinois. Case Files electronically transmitted. (afar) |
Oct 22, 2021 | 51 | Order on Motion to Dismiss (11) Docket Text: MEMORANDUM OPINION AND ORDER: The Court GRANTS Defendant's Motion to Transfer. Accordingly, the Court FINDS Defendant's Motion to Dismiss MOOT. It is ORDERED that this case be TRANSFERRED to the U.S. District Court for the Northern District of Illinois. Signed by District Judge Raymond A. Jackson on 10/21/2021. (afar) |
Sep 24, 2021 | 49 | Motion to Withdraw as Attorney () (3) Docket Text: MOTION to Withdraw as Attorney Jennifer L. Eaton by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Proposed Order Proposed Order)(Eaton, Jennifer) |
Sep 24, 2021 | 49 | Motion to Withdraw as Attorney (Proposed Order Proposed Order) (1) Docket Text: MOTION to Withdraw as Attorney Jennifer L. Eaton by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Proposed Order Proposed Order)(Eaton, Jennifer) |
Sep 24, 2021 | 50 | Memorandum in Support (3) Docket Text: Memorandum in Support re [49] MOTION to Withdraw as Attorney Jennifer L. Eaton filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Eaton, Jennifer) |
Aug 24, 2021 | 48 | NOTICE () (2) Docket Text: NOTICE by Abbvie Biotechnology Ltd., Abbvie Inc re [32] MOTION to Dismiss or, in the alternative, to Transfer (Attachments: # (1) Exhibit Memorandum Opinion and Order)(Ottinger, Richard) |
Aug 24, 2021 | 48 | NOTICE (Exhibit Memorandum Opinion and Order) (30) Docket Text: NOTICE by Abbvie Biotechnology Ltd., Abbvie Inc re [32] MOTION to Dismiss or, in the alternative, to Transfer (Attachments: # (1) Exhibit Memorandum Opinion and Order)(Ottinger, Richard) |
Jun 22, 2021 | 46 | Reply to Response to Motion (28) Docket Text: REPLY to Response to Motion re [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration () (2) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration (Exhibit 28) (3) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration (Exhibit 29) (7) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration (Exhibit 30) (4) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration (Exhibit 31) (5) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 22, 2021 | 47 | Declaration (Exhibit 32) (4) Docket Text: Declaration re [46] Reply to Response to Motion - Declaration of Herman H. Yue in Support of Defendants' Reply by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32)(Ottinger, Richard) |
Jun 17, 2021 | 45 | Request for Hearing (3) Docket Text: Request for Hearing by Alvotech USA Inc., Alvotech hf. re [32] MOTION to Dismiss or, in the alternative, to Transfer (Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition () (30) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Oppo) (3) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit A) (4) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit B) (6) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit C) (30) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit D) (23) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit E) (3) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit F) (2) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit G) (8) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit H) (5) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit I) (2) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 16, 2021 | 44 | Opposition (Exhibit J) (4) Docket Text: Opposition to [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Declaration of Ahmed J. Davis In Support of Plaintiffs' Memorandum In Opposition to Defendants' Motion to Dismiss Or, In The Alternative, to Transfer, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(Davis, Ahmed) |
Jun 15, 2021 | 42 | Order on Motion to Amend/Correct (1) Docket Text: AGREED ORDER granting [40] Motion to Amend/Correct Memorandum in Support. ENTERED AS MODIFIED BY THE COURT. Signed by Magistrate Judge Douglas E. Miller on 6/15/21. (jhie, ) |
Jun 15, 2021 | 43 | Memorandum in Support (30) Docket Text: Memorandum in Support re [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 14, 2021 | N/A | Motions Referred (0) Docket Text: MOTION REFERRED to Magistrate Judge Douglas E. Miller: [40] Consent MOTION to Amend/Correct [33] Memorandum in Support (jhie, ) |
Jun 10, 2021 | 40 | Motion to Amend/Correct () (3) Docket Text: Consent MOTION to Amend/Correct [33] Memorandum in Support by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1 - Amended Memorandum, # (2) Proposed Order Proposed Order)(Ottinger, Richard) |
Jun 10, 2021 | 40 | Motion to Amend/Correct (Exhibit 1 - Amended Memorandum) (30) Docket Text: Consent MOTION to Amend/Correct [33] Memorandum in Support by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1 - Amended Memorandum, # (2) Proposed Order Proposed Order)(Ottinger, Richard) |
Jun 10, 2021 | 40 | Motion to Amend/Correct (Proposed Order Proposed Order) (1) Docket Text: Consent MOTION to Amend/Correct [33] Memorandum in Support by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1 - Amended Memorandum, # (2) Proposed Order Proposed Order)(Ottinger, Richard) |
Jun 10, 2021 | 41 | Memorandum in Support () (3) Docket Text: Memorandum in Support re [40] Consent MOTION to Amend/Correct [33] Memorandum in Support filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1 - Amended Memorandum)(Ottinger, Richard) |
Jun 10, 2021 | 41 | Memorandum in Support (Exhibit 1 - Amended Memorandum) (30) Docket Text: Memorandum in Support re [40] Consent MOTION to Amend/Correct [33] Memorandum in Support filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1 - Amended Memorandum)(Ottinger, Richard) |
Jun 4, 2021 | 36 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [27] Motion for Pro hac vice for Charles Collins-Chase as to Abbvie Biotechnology Ltd. and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/4/21. (tlev, ) |
Jun 4, 2021 | 37 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [28] Motion for Pro hac vice for Kassandra M. Officer as to Abbvie Biotechnology Ltd and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/4/21. (tlev, ) |
Jun 4, 2021 | 38 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [29] Motion for Pro hac vice for William B. Raich as to Abbvie Biotechnology Ltd and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/4/21. (tlev, ) |
Jun 4, 2021 | 39 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [30] Motion for Pro hac vice for Oulu Wang as to Abbvie Biotechnology Ltd and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/4/21. (tlev, ) |
Jun 2, 2021 | 27 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Charles Collins-Chase and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7821204. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 28 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Kassandra M. Officer and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7821217. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 29 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by William B. Raich and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7821224. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 30 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Oulu Wang and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7821231. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 31 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Dustin Mitchell Paul on behalf of Abbvie Biotechnology Ltd., Abbvie Inc (Paul, Dustin) |
Jun 2, 2021 | 32 | Motion to Dismiss (3) Docket Text: MOTION to Dismiss or, in the alternative, to Transfer by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 33 | Memorandum in Support (30) Docket Text: Memorandum in Support re [32] MOTION to Dismiss or, in the alternative, to Transfer filed by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 34 | Declaration (6) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Sowmyan Ranganathan) by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration () (6) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 1) (5) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 2) (3) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 3) (3) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 4) (3) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 5) (4) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 6) (4) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 7) (6) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 8) (2) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 9) (12) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 10) (10) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 11) (10) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 12) (5) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 13) (6) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 14) (11) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 15) (5) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 16) (30) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 17) (4) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 18) (10) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 19) (13) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 20) (7) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 21) (2) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 22) (4) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 23) (4) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 24) (2) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 25) (6) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 26) (8) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 2, 2021 | 35 | Declaration (Exhibit 27) (7) Docket Text: Declaration re [33] Memorandum in Support (Declaration of Herman H. Yue) by Abbvie Biotechnology Ltd., Abbvie Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27)(Ottinger, Richard) |
Jun 1, 2021 | 23 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [19] Motion for Pro hac vice for David Penn Frazier as to Abbvie Biotechnology Ltd. and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/1/21. (tlev, ) |
Jun 1, 2021 | 24 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [18] Motion for Pro hac vice for Herman Heng Yue as to Abbvie Biotechnology Ltd. and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/1/21. (tlev, ) |
Jun 1, 2021 | 25 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [21] Motion for Pro hac vice for Tara D Elliott as to Abbvie Biotechnology Ltd. and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/1/21. (tlev, ) |
Jun 1, 2021 | 26 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [20] Motion for Pro hac vice for Michael A. Morin as to Abbvie Biotechnology Ltd. and Abbvie Inc. Signed by District Judge Raymond A. Jackson on 6/1/21. (tlev, ) |
May 28, 2021 | 17 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jennifer Lynn Eaton on behalf of Abbvie Biotechnology Ltd., Abbvie Inc (Eaton, Jennifer) |
May 28, 2021 | 18 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Herman H. Yue and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7815417. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
May 28, 2021 | 19 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by David P. Frazier and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7815438. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
May 28, 2021 | 20 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Michael A. Morin and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7815457. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
May 28, 2021 | 21 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Tara D. Elliott and Certification of Local Counsel Richard H. Ottinger Filing fee $ 75, receipt number AVAEDC-7815466. by Abbvie Biotechnology Ltd., Abbvie Inc. (Ottinger, Richard) |
May 28, 2021 | 22 | Summons Returned Executed (4) Docket Text: SUMMONS Returned Executed by Alvotech USA Inc., Alvotech hf. (Davis, Ahmed) |
May 27, 2021 | 13 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Richard Hooper Ottinger on behalf of Abbvie Biotechnology Ltd., Abbvie Inc (Ottinger, Richard) |
May 27, 2021 | 14 | Financial Disclosure Statement (2) Docket Text: Financial Interest Disclosure Statement (Local Rule 7.1) by Abbvie Biotechnology Ltd.. (Ottinger, Richard) |
May 27, 2021 | 15 | Financial Disclosure Statement (1) Docket Text: Financial Interest Disclosure Statement (Local Rule 7.1) by Abbvie Inc. (Ottinger, Richard) |
May 27, 2021 | 16 | Summons Returned Executed (12) Docket Text: SUMMONS Returned Executed by Alvotech USA Inc., Alvotech hf. Abbvie Biotechnology Ltd. served on 5/25/2021, answer due 6/15/2021 (Davis, Ahmed) |
May 24, 2021 | 12 | Summons Returned Executed (4) Docket Text: SUMMONS Returned Executed by Alvotech USA Inc., Alvotech hf. Abbvie Inc served on 5/12/2021, answer due 6/2/2021 (Davis, Ahmed) |
May 19, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to District Judge Raymond A. Jackson. District Judge Robert G. Doumar no longer assigned to the case. (afar) |
May 19, 2021 | 9 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [6] Motion for Pro hac vice for Douglas Edward McCann as to Alvotech USA Inc. and Alvotech hf. Signed by District Judge Raymond A. Jackson on 5/19/21. (tlev, ) |
May 19, 2021 | 10 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [7] Motion for Pro hac vice for Jonathan Singer as to Alvotech USA Inc. and Alvotech hf. Signed by District Judge Raymond A. Jackson on 5/19/21. (tlev, ) |
May 19, 2021 | 11 | Order on Motion for Pro hac vice (1) Docket Text: ORDER granting [8] Motion for Pro hac vice for Martina Tyreus Hufnal as to Alvotech USA Inc. and Alvotech hf. Signed by District Judge Raymond A. Jackson on 5/19/21. (tlev, ) |
May 17, 2021 | 7 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Jonathan Singer and Certification of Local Counsel Ahmed J. Davis Filing fee $ 75, receipt number AVAEDC-7790766. by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |
May 17, 2021 | 8 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Martina Tyreus Hufnal and Certification of Local Counsel Ahmed J. Davis Filing fee $ 75, receipt number AVAEDC-7792166. by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |
May 14, 2021 | 6 | Motion to appear Pro hac vice (1) Docket Text: Motion to appear Pro Hac Vice by Douglas Edward McCann and Certification of Local Counsel Ahmed J. Davis Filing fee $ 75, receipt number AVAEDC-7788112. by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |
May 12, 2021 | N/A | Case Transferred In - Divisional Transfer (0) Docket Text: Case transferred in from Alexandria Division. Case Number 1:21cv589. (afar) |
May 12, 2021 | 5 | Summons Issued () (4) Docket Text: Summons Issued as to Abbvie Biotechnology Ltd., Abbvie Inc. NOTICE TO ATTORNEY: Print out two electronically issued summons and one copy of the attachments for each defendant to be served with the complaint. (Attachments: # (1) Civil Motions Procedures)(jhie, ) |
May 12, 2021 | 5 | Summons Issued (Civil Motions Procedures) (2) Docket Text: Summons Issued as to Abbvie Biotechnology Ltd., Abbvie Inc. NOTICE TO ATTORNEY: Print out two electronically issued summons and one copy of the attachments for each defendant to be served with the complaint. (Attachments: # (1) Civil Motions Procedures)(jhie, ) |
May 11, 2021 | 1 | Complaint* (1) |
May 11, 2021 | 1 | Complaint () (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 1) (3) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 2) (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 3) (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 4) (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 5) (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 6) (5) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 7) (6) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 8) (3) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 9) (12) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Exhibit 10) (30) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 1 | Complaint (Civil Cover Sheet) (2) Docket Text: Complaint ( Filing fee $ 402, receipt number AVAEDC-7780694.), filed by Alvotech USA Inc., Alvotech hf.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Civil Cover Sheet)(Davis, Ahmed) |
May 11, 2021 | 2 | Proposed Summons (2) Docket Text: Proposed Summons to AbbVie Inc. by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |
May 11, 2021 | 3 | Proposed Summons (2) Docket Text: Proposed Summons AbbVie Biotechnology Ltd by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |
May 11, 2021 | 4 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Alvotech USA Inc., Alvotech hf.. (Davis, Ahmed) |